melanoma vaccine (Metacine)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namemelanoma vaccine (Metacine)

Drug Alias Namemelanoma vaccines (Univ of Pittsburgh)

ClassificationBiologics > Protein drugs > Recombinant polypeptideVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Dendritic cell vaccine

Mechanisms of ActionGlucan synthesis modulators

TargetsNot applicable

Therapy Area/IndicationsMelanoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesUniversity Of Pittsburgh

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesMetacine

Active IndicationsN/A

Inactive IndicationsMelanoma

Other Information

ATC CodeN/A